| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | Chief Medical Officer | Common Stock | 35.5K | $669K | $18.84 | Nov 25, 2025 | Direct |
| Bicara Therapeutics Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 69.4K | Nov 25, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | Nov 24, 2025 | 9 | -$163K | 4 | Nov 25, 2025 | Chief Medical Officer |
| BCAX | Bicara Therapeutics Inc. | Oct 9, 2025 | 3 | -$323K | 4 | Oct 10, 2025 | Chief Medical Officer |
| BCAX | Bicara Therapeutics Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Chief Medical Officer |